Seniors Across Alabama, Georgia and Tennessee Get Access to Living Cell Therapy to Heal Difficult Chronic Ulcers
TheraSkin®, a biologically active real skin wound therapy, now covered for Medicare Beneficiaries thanks to decision by Cahaba GBA. TheraSkin®: now the only real human skin substitute with living cells to have Medicare coverage in 100% of hospital based wound centers in the U.S. and its territories
Newport News, VA (May 1, 2015) – Soluble Systems, LLC announced today that Cahaba GBA, the Medicare Part A & Part B Contractor (A/B MAC) for Jurisdiction 10, has decided to provide reimbursement coverage for TheraSkin® when used for the treatment of poorly healing diabetic foot and venous leg ulcers.
This is good news for the 3.3 million Medicare-eligible Seniors in AL, GA and TN and very good news indeed for the estimated 27% who have diabetes and are likely to develop diabetic foot ulcers and venous leg ulcers. These ulcers are often difficult to heal and, when all else fails, are involved in nearly two-thirds of all non-traumatic lower limb amputations each year.
“We are pleased that Cahaba has decided to cover TheraSkin® for J10 Medicare recipients,” said Kerry McCarter, Executive Chairman of the Board of Soluble Systems, LLC, the parent company of TheraSkin®. He explained; “Patients with diabetic and venous leg ulcers will now have access to the highly effective living cell therapy provided by TheraSkin®. Living cell therapy has been cited as the “gold standard” of care for these types of wounds.”
TheraSkin®, a real skin therapy, offers real help. A recently published peer-reviewed research study involving 188 patients shows that TheraSkin® heals over 60% of these “non-healing” ulcers in 12 weeks with an average of only 2 applications.
What is TheraSkin®? TheraSkin® is a biologically active cryopreserved human skin allograft for non-responsive chronic wounds. TheraSkin’s fully developed extracellular matrix (ECM) and living cells provide an “at-ready” supply of human growth factors, cytokines and collagen to jumpstart wound healing. TheraSkin® provides necessary growth factors and cytokines AND a large quantity of essential human collagens in appropriate ratios to support healing. This allows TheraSkin® to be used on more severe wounds with exposed bone, tendon, joint capsules or muscle.
Soluble Systems, LLC has partnered with the Skin and Wound Allograft Institute (SWAI), a wholly owned subsidiary of LifeNet Health, to bring TheraSkin® to market. LifeNet Health is the world’s largest provider of bio-implants and organs for transplantation.